Minimal prevalence of HPV vaccination and common occurrence of high-risk HPV types in pregnant women with HIV: data from a national study in Italy

Marco Floridia,Giulia Masuelli,Beatrice Tassis,Valeria M. Savasi,Matilde Sansone,Arsenio Spinillo,Laura Franceschetti,Giovanni Guaraldi,Carmela Pinnetti,Serena Dalzero,Alessandra Meloni,Antonella Vimercati,Giuliana Simonazzi,Enrica Tamburrini,Marina Ravizza,
DOI: https://doi.org/10.1007/s10096-021-04393-1
2022-01-09
Abstract:Among 733 pregnant women with HIV followed between 2013 and 2021, only 8 (1.1%) had prior HPV vaccination. One had low-grade squamous intraepithelial lesions [LSIL], and none had HPV type information. Among the 725 non-vaccinated women, 578 (79.7%) had information on cervical cytology. Rate of cytologic abnormalities in this group was 20.6% (0.2% atypical glandular cells of undetermined significance [AGC], 1.7% atypical squamous cells of undetermined significance [ASC-US], 11.1% LSIL, and 7.6% high-grade squamous intraepithelial lesions [HSIL]). Among 56 women with HPV type information, 75.0% carried high risk types, with similar occurrence in women with and without cytologic abnormalities, 30.4% had multiple high-risk types, and 75.9% carried at least one of the types included in the currently recommended 9-valent vaccine.
infectious diseases,microbiology
What problem does this paper attempt to address?